Published in Chest on January 01, 2005
Device Mixing in Asthma, a General Practice Research Database Study (EBsalbutamol) | NCT01313585
Efficacy of an Education Protocol in the Correction of Inhalation Techniques in COPD | NCT03144557
Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis (2008) 1.99
International consensus on (ICON) pediatric asthma. Allergy (2012) 1.79
Misuse of respiratory inhalers in hospitalized patients with asthma or COPD. J Gen Intern Med (2011) 1.55
Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Allergy Asthma Clin Immunol (2013) 1.51
Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPD. Int J Chron Obstruct Pulmon Dis (2011) 1.35
Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler. Int J Chron Obstruct Pulmon Dis (2009) 1.32
Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 1.18
Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomedicine (2012) 1.18
Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India (2013) 1.13
Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control. BMC Pulm Med (2009) 1.10
Use of Respimat Soft Mist inhaler in COPD patients. Int J Chron Obstruct Pulmon Dis (2006) 1.08
Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting. Int J Chron Obstruct Pulmon Dis (2012) 1.08
In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review. AAPS PharmSciTech (2007) 1.07
Ease-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian population. Lung India (2014) 1.06
Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care. Allergy Asthma Immunol Res (2012) 0.92
The challenge of delivering therapeutic aerosols to asthma patients. ISRN Allergy (2013) 0.91
Feasibility of tissue plasminogen activator formulated for pulmonary delivery. Pharm Res (2005) 0.90
Considerations for managing chronic obstructive pulmonary disease in the elderly. Clin Interv Aging (2013) 0.90
In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) system. J Aerosol Med Pulm Drug Deliv (2010) 0.90
Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations. Ther Clin Risk Manag (2008) 0.89
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD. Int J Chron Obstruct Pulmon Dis (2012) 0.89
Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners. J Aerosol Med Pulm Drug Deliv (2014) 0.88
Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD. Patient Relat Outcome Meas (2014) 0.87
Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation. BMC Pulm Med (2011) 0.87
Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend. Am Health Drug Benefits (2014) 0.86
Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler. Br J Clin Pharmacol (2008) 0.85
Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease. J Aerosol Med Pulm Drug Deliv (2010) 0.85
How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze. NPJ Prim Care Respir Med (2015) 0.84
Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma. Int J Clin Pract (2007) 0.84
Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations. J Pharm Sci (2013) 0.82
Safety and efficacy of fluticasone propionate/salmeterol hydrofluoroalkane 134a metered-dose-inhaler compared with fluticasone propionate/salmeterol diskus in patients with chronic obstructive pulmonary disease. Open Respir Med J (2010) 0.82
Effectiveness of inhaler types for real-world asthma management: retrospective observational study using the GPRD. J Asthma Allergy (2011) 0.82
Choosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly. Clin Mol Allergy (2015) 0.82
Evaluating inhaler use technique in COPD patients. Int J Chron Obstruct Pulmon Dis (2015) 0.82
The role of omalizumab in the treatment of severe allergic asthma. Can Respir J (2006) 0.81
Management of asthma in the elderly patient. Clin Interv Aging (2013) 0.80
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting. J Asthma (2016) 0.80
Is 'GOLD' standard for the management of COPD in clinical practice? Drugs Context (2012) 0.79
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study. Clinicoecon Outcomes Res (2010) 0.79
Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment options. Patient Prefer Adherence (2010) 0.78
Developing ways to evaluate in the laboratory how inhalation devices will be used by patients and care-givers: the need for clinically appropriate testing. AAPS PharmSciTech (2014) 0.78
Integrated management strategies for chronic obstructive pulmonary disease. J Multidiscip Healthc (2010) 0.78
Switching treatments in COPD: implications for costs and treatment adherence. Int J Chron Obstruct Pulmon Dis (2015) 0.78
Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers? Osteoporos Int (2009) 0.77
Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data. Int J Chron Obstruct Pulmon Dis (2016) 0.77
Aerosolized Delivery of Antifungal Agents. Curr Fungal Infect Rep (2010) 0.77
Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.77
Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD. Drugs R D (2013) 0.77
Asthma that is unresponsive to usual care. CMAJ (2009) 0.77
Nebulized formoterol: a review of clinical efficacy and safety in COPD. Int J Chron Obstruct Pulmon Dis (2010) 0.76
Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients. Clin Interv Aging (2013) 0.76
Asthma in adults. BMJ Clin Evid (2010) 0.75
Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review. NPJ Prim Care Respir Med (2017) 0.75
Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Impact of multiple-dose versus single-dose inhaler devices on COPD patients' persistence with long-acting β₂-agonists: a dispensing database analysis. NPJ Prim Care Respir Med (2014) 0.75
Ciclesonide in persistent asthma: the evidence of its therapeutic value. Core Evid (2006) 0.75
Best Treatment Guidelines For Bronchial Asthma. Med J Armed Forces India (2011) 0.75
Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations. Pharmacoeconomics (2017) 0.75
Patients' perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®). Patient Prefer Adherence (2016) 0.75
Inhaler Use in Hospitalized Patients with Chronic Obstructive Pulmonary Disease or Asthma: Assessment of Wasted Doses. Hosp Pharm (2015) 0.75
Asthma in adults (acute). BMJ Clin Evid (2011) 0.75
A nurse-led intervention study: Promoting compliance with Diskus Inhaler use in asthma patients. Nurs Open (2014) 0.75
Efficacy and safety of the single-capsule combination of fluticasone/formoterol in patients with persistent asthma: a non-inferiority trial. J Bras Pneumol (2015) 0.75
Patient perspectives on fluticasone-vilanterol versus other corticosteroid combination products for the treatment of asthma. Patient Prefer Adherence (2016) 0.75
Real-world asthma management with inhaler devices in Switzerland-results of the asthma survey. J Thorac Dis (2016) 0.75
Safety of daily albuterol in infants with a history of bronchospasm: a multi-center placebo controlled trial. Open Respir Med J (2009) 0.75
Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthma. Ther Clin Risk Manag (2015) 0.75
Aerosol delivery devices. Chest (2006) 0.75
A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old. J Aerosol Med Pulm Drug Deliv (2015) 0.75
Asthma Review for Pharmacists Providing Asthma Education. J Pediatr Pharmacol Ther (2016) 0.75
Chronic obstructive pulmonary disease: an overview. Am Health Drug Benefits (2008) 0.75
Fundamentals of aerosol therapy in critical care. Crit Care (2016) 0.75
Aerosol therapy for obstructive lung diseases: device selection and practice management issues. Chest (2011) 0.75
Do Face-to-Face Training and Telephonic Reminder Improve Dry Powder Inhaler Technique in Patients with COPD? Int J Telemed Appl (2017) 0.75
A review of nebulized drug delivery in COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β2-Agonists. Drugs Real World Outcomes (2016) 0.75
Improving outcomes in chronic obstructive pulmonary disease: the role of the interprofessional approach. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Review: various devices for delivery of aerosol treatment can be equally efficacious. Evid Based Nurs (2005) 0.75
Inhalation devices. CMAJ (2005) 0.75
Delivery of beta-agonists in the emergency department setting: metered-dose inhalers or nebulizers? Chest (2005) 0.75
Evaluation of proficiency in using different inhaler devices among intern doctors. J Family Med Prim Care (2016) 0.75
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT). NPJ Prim Care Respir Med (2016) 0.75
An evaluation of impact of educational interventions on the technique of use of metered-dose inhaler by patients. Indian J Pharmacol (2017) 0.75
Safety of Nebulized Epinephrine in Smoke Inhalation Injury. J Burn Care Res (2017) 0.75
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet (2008) 13.15
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet (2011) 9.31
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) (2012) 9.25
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med (2001) 8.95
ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med (2003) 8.83
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94
Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med (2003) 7.32
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12
Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10
An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29
Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ (2002) 4.70
Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med (2011) 4.59
Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58
Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.49
Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.29
Evaluating the teaching of evidence-based medicine. JAMA (2002) 4.01
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 4.01
Clinical experts or methodologists to write clinical guidelines? Lancet (2009) 3.91
Interventions to reduce unintended pregnancies among adolescents: systematic review of randomised controlled trials. BMJ (2002) 3.90
Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 3.86
The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.74
GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol (2013) 3.58
Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians. Chest (2003) 3.55
Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev (2002) 3.46
Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 3.46
Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 3.41
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.36
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest (2007) 3.36
Patients at the center: in our practice, and in our use of language. ACP J Club (2004) 3.32
Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.31
Randomized controlled trials of surgical interventions. Ann Surg (2010) 3.30
Naturopathic medicine for the prevention of cardiovascular disease: a randomized clinical trial. CMAJ (2013) 3.25
Tips for learning and teaching evidence-based medicine: introduction to the series. CMAJ (2004) 3.23
A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med (2006) 3.16
The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. Am J Respir Crit Care Med (2008) 3.01
Randomized trial of reamed and unreamed intramedullary nailing of tibial shaft fractures. J Bone Joint Surg Am (2008) 3.01
Aerosol drug delivery: developments in device design and clinical use. Lancet (2010) 2.92
An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units. Am J Respir Crit Care Med (2015) 2.86
Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.83
Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit. Am J Respir Crit Care Med (2014) 2.80
Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med (2011) 2.80
Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 2.74
Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.72
Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med (2008) 2.65
Clinician predictions of intensive care unit mortality. Crit Care Med (2004) 2.65
Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.60
Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.56
Cooling for neonatal hypoxic ischemic encephalopathy: do we have the answer? Pediatrics (2007) 2.51
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.50
Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev (2002) 2.49
Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol (2003) 2.47
Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.47
GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol (2013) 2.46
Grades of recommendation for antithrombotic agents. Chest (2001) 2.44
Evidence based medicine has come a long way. BMJ (2004) 2.42
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol (2008) 2.31
Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med (2010) 2.28
Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurol (2006) 2.23
Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep (2003) 2.21
Early stopping of randomized clinical trials for overt efficacy is problematic. J Clin Epidemiol (2008) 2.18
Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*. Crit Care Med (2015) 2.16
Family impact of child oral and oro-facial conditions. Community Dent Oral Epidemiol (2002) 2.09
The solitary pulmonary nodule. Chest (2003) 2.09
Clonidine in patients undergoing noncardiac surgery. N Engl J Med (2014) 2.07
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06
Effect of face mask design on inhaled mass of nebulized albuterol, using a pediatric breathing model. Respir Care (2007) 2.03
The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study. PLoS One (2011) 2.02
Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest (2007) 2.02
Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 2.00
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest (2007) 1.99
Barriers to participating in an HIV vaccine trial: a systematic review. AIDS (2004) 1.97
Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med (2001) 1.95
Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.94